Galmed Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update

Go back to Galmed Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update

Galmed Pharma (GLMD) Misses Q1 EPS by 3c

May 16, 2016 8:04 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More